FDA Develops Formal Procedure To Refer Misleading Communications To SEC
This article was originally published in The Pink Sheet Daily
Executive Summary
Associate Commissioner for Regulatory Affairs John Taylor will serve as the liaison between the agencies. FDA will provide "blanket" authorization to certain staff to share non-public information with SEC.